Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Geron Corporation

< Previous 1 2 3 4 Next >
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at Upcoming Investor Conferences in April
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Proposed Public Offering of Common Stock
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Participate in Stifel 2022 Healthcare Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at Upcoming Investor Conferences
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports Second Quarter 2022 Financial Results
From Geron Corporation
Via Business Wire
Tickers GERN
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.